Sarah Scagliarini, Medical Oncologist at AORN Cardarelli in Naples, shared on X:
“Italy at ESMO26.
Masters, colleagues and friends showcasing innovation, simultaneous publications, independent research, impactful trials, insightful discussions, rarity, and clarity in personalization strategy for GU cancer patients.
So proud, inspired and motivated to keep moving forward!”
You can also read: KEYNOTE-866 at ESMO 2026: Perioperative Pembrolizumab Plus Chemotherapy in Muscle-Invasive Bladder Cancer
